Published in J Exp Clin Cancer Res on November 07, 2013
A comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT. Radiat Oncol (2015) 0.98
Review of deep inspiration breath-hold techniques for the treatment of breast cancer. J Med Radiat Sci (2015) 0.93
Breast cancer therapy-associated cardiovascular disease. Nat Rev Clin Oncol (2015) 0.83
Determination of the optimal matching position for setup images and minimal setup margins in adjuvant radiotherapy of breast and lymph nodes treated in voluntary deep inhalation breath-hold. Radiat Oncol (2015) 0.78
Is the Deep Inspiration Breath-Hold Technique Superior to the Free Breathing Technique in Cardiac and Lung Sparing while Treating both Left-Sided Post-Mastectomy Chest Wall and Supraclavicular Regions? Case Rep Oncol (2017) 0.75
External beam boost versus interstitial high-dose-rate brachytherapy boost in the adjuvant radiotherapy following breast-conserving therapy in early-stage breast cancer: a dosimetric comparison. J Contemp Brachytherapy (2016) 0.75
Treatment planning and evaluation of gated radiotherapy in left-sided breast cancer patients using the Catalyst(TM)/Sentinel(TM) system for deep inspiration breath-hold (DIBH). Radiat Oncol (2016) 0.75
Use of a correlation analysis model in the optimization of intensity-modulated radiotherapy of prostate cancer. Exp Ther Med (2015) 0.75
Selection of patients with left breast cancer for deep-inspiration breath-hold radiotherapy technique: Results of a prospective study. Rep Pract Oncol Radiother (2017) 0.75
The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys (2006) 6.93
Complication probability as assessed from dose-volume histograms. Radiat Res Suppl (1985) 3.85
Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation. Phys Med Biol (2002) 2.70
Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys (2010) 2.66
Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys (2003) 2.41
Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys (2003) 1.78
Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys (1998) 1.76
Long-term cardiac mortality after radiotherapy of breast cancer--application of the relative seriality model. Br J Radiol (1996) 1.71
Tracking the dose distribution in radiation therapy by accounting for variable anatomy. Phys Med Biol (2004) 1.61
The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol (1994) 1.53
Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Radiother Oncol (2004) 1.46
Breathing adapted radiotherapy for breast cancer: comparison of free breathing gating with the breath-hold technique. Radiother Oncol (2005) 1.37
Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients. Int J Radiat Oncol Biol Phys (2001) 1.36
Patient training in respiratory-gated radiotherapy. Med Dosim (2003) 1.23
Postoperative irradiation of left-sided breast cancer patients and cardiac toxicity. Does deep inspiration breath-hold (DIBH) technique protect the heart? Strahlenther Onkol (2008) 1.22
The impact of central lung distance, maximal heart distance, and radiation technique on the volumetric dose of the lung and heart for intact breast radiation. Int J Radiat Oncol Biol Phys (2002) 1.18
Impact of breathing motion on whole breast radiotherapy: a dosimetric analysis using active breathing control. Int J Radiat Oncol Biol Phys (2004) 1.18
Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001. Radiother Oncol (2011) 1.13
Reduction of cardiac volume in left-breast treatment fields by respiratory maneuvers: a CT study. Int J Radiat Oncol Biol Phys (2000) 1.13
Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model. Radiother Oncol (2000) 1.03
IsoBED: a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique. J Exp Clin Cancer Res (2011) 0.93
Evaluation of dose to cardiac structures during breast irradiation. Br J Radiol (2010) 0.92
The effects of tumor motion on planning and delivery of respiratory-gated IMRT. Med Phys (2003) 0.88
Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years. J Exp Clin Cancer Res (2010) 0.87
Influence of respiration-induced organ motion on dose distributions in treatments using enhanced dynamic wedges. Med Phys (2001) 0.85
Impact of respiratory maneuvers on cardiac volume within left-breast radiation portals. Circulation (1997) 0.82
The effects of intrafraction motion on dose homogeneity in a breast phantom with physical wedges, enhanced dynamic wedges, and ssIMRT. Int J Radiat Oncol Biol Phys (2006) 0.81
A single isocenter technique using CT-based planning in the treatment of breast cancer. Med Dosim (1999) 0.78
Proteins of the PDI family: unpredicted non-ER locations and functions. J Cell Physiol (2002) 2.75
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys (2010) 2.66
Twenty years of radiobiology in clinical practice: the Italian contribution. Tumori (2015) 1.98
HP1 controls telomere capping, telomere elongation, and telomere silencing by two different mechanisms in Drosophila. Mol Cell (2004) 1.74
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2010) 1.68
Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer. Int J Radiat Oncol Biol Phys (2012) 1.60
Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J Clin Invest (2009) 1.51
A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer. Int J Radiat Oncol Biol Phys (2005) 1.49
Phase I-II study of intraoperative radiation therapy (IORT) after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys (2008) 1.46
Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys (2013) 1.45
Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations. J Nucl Med (2010) 1.42
Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity. Radiother Oncol (2006) 1.16
Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials. Cancer (2009) 1.13
Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer. Endocr Relat Cancer (2012) 1.12
Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (2009) 1.05
Nuclear localization and DNA interaction of protein disulfide isomerase ERp57 in mammalian cells. J Cell Biochem (2002) 1.02
Setup verification and in vivo dosimetry during intraoperative radiation therapy (IORT) for prostate cancer. Med Phys (2007) 0.97
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: meta-analysis of randomized trials. BMC Cancer (2010) 0.94
Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial. Int J Radiat Oncol Biol Phys (2012) 0.94
Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer. J Exp Clin Cancer Res (2009) 0.94
IsoBED: a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique. J Exp Clin Cancer Res (2011) 0.93
In vivo dosimetry with MOSFETs: dosimetric characterization and first clinical results in intraoperative radiotherapy. Int J Radiat Oncol Biol Phys (2005) 0.92
ERp57 is present in STAT3-DNA complexes. Biochem Biophys Res Commun (2004) 0.92
Preliminary studies for a CBCT imaging protocol for offline organ motion analysis: registration software validation and CTDI measurements. Med Dosim (2010) 0.92
A feasibility dosimetric study on prostate cancer : are we ready for a multicenter clinical trial on SBRT? Strahlenther Onkol (2015) 0.91
Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line. Arch Biochem Biophys (2009) 0.91
Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area. Radiother Oncol (2007) 0.90
Relationships between rectal wall dose-volume constraints and radiobiologic indices of toxicity for patients with prostate cancer. Int J Radiat Oncol Biol Phys (2007) 0.90
Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases. J Neurooncol (2008) 0.90
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy. J Nucl Med (2015) 0.89
Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis. Heart Rhythm (2014) 0.88
The stress protein ERp57/GRP58 binds specific DNA sequences in HeLa cells. J Cell Physiol (2007) 0.87
A study of the effect of setup errors and organ motion on prostate cancer treatment with IMRT. Int J Radiat Oncol Biol Phys (2006) 0.87
Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years. J Exp Clin Cancer Res (2010) 0.87
Abscopal effect of radiation therapy: Interplay between radiation dose and p53 status. Int J Radiat Biol (2014) 0.87
A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2010) 0.86
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of articledeveloping erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery. BMC Cancer (2011) 0.84
Early radiation-induced changes evaluated by intravoxel incoherent motion in the major salivary glands. J Magn Reson Imaging (2014) 0.84
Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2009) 0.84
Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial. Int J Radiat Oncol Biol Phys (2008) 0.83
Influence of intensity-modulated radiation therapy technique on xerostomia and related quality of life in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer. Head Neck (2011) 0.82
Immunoprecipitation of DNA-protein complexes cross-linked by cis-diamminedichloroplatinum. Anal Biochem (2002) 0.82
Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma. Radiat Oncol (2012) 0.82
Implementation of a new cost efficacy method for blood irradiation using a non dedicated device. J Exp Clin Cancer Res (2011) 0.82
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors. Theor Biol Med Model (2012) 0.82
Repeat stereotactic radiosurgery in the management of brain metastases from NSCLC: A case report and review of the literature. Oncol Lett (2013) 0.82
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases. Eur J Nucl Med Mol Imaging (2013) 0.82
Modeling the positioning of single needle electrodes for the treatment of breast cancer in a clinical case. Biomed Eng Online (2015) 0.81
Radiation protection measurements around a 12 MeV mobile dedicated IORT accelerator. Med Phys (2010) 0.81
Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT. Eur J Radiol (2011) 0.81
Cryothermic ablation within the coronary sinus of an epicardial posterolateral pathway. J Cardiovasc Electrophysiol (2002) 0.80
Is the in vivo dosimetry with the OneDosePlusTM system able to detect intra-fraction motion? A retrospective analysis of in vivo data from breast and prostate patients. Radiat Oncol (2012) 0.80
Serum p53 antibody detection in patients with impaired lung function. BMC Cancer (2013) 0.80
Patient positioning in the proton radiotherapy era. J Exp Clin Cancer Res (2010) 0.80
Monte Carlo dose voxel kernel calculations of beta-emitting and Auger-emitting radionuclides for internal dosimetry: A comparison between EGSnrcMP and EGS4. Med Phys (2006) 0.79
Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control. J Exp Clin Cancer Res (2013) 0.79
Tomotherapy treatment plan quality assurance: the impact of applied criteria on passing rate in gamma index method. Med Phys (2013) 0.79
Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound. J Exp Clin Cancer Res (2013) 0.79
Interaction of EBV latent origin of replication with the nuclear matrix: identification of S/MAR sequences and protein components. FEBS Lett (2003) 0.79
Preliminary results of 45 patients with trigeminal neuralgia treated with radiosurgery compared to hypofractionated stereotactic radiotherapy, using a dedicated linear accelerator. J Clin Neurosci (2012) 0.78
Potential third-party radiation exposure from patients undergoing therapy with 131I for thyroid cancer or metastases. Health Phys (2015) 0.78
In regard to Miralbell et al. Re: Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5969 patients in seven international institutional datasets: alpha/beta=1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys (2013) 0.78
A new model for predicting acute mucosal toxicity in head-and-neck cancer patients undergoing radiotherapy with altered schedules. Int J Radiat Oncol Biol Phys (2012) 0.78
Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer. Radiat Oncol (2011) 0.78
Tissue heterogeneity in IMRT dose calculation for lung cancer. Med Dosim (2010) 0.78
Abscopal effect of radiation therapy: interplay between radiation dose and p53 status. Int J Radiat Biol (2015) 0.77
Biological optimization of heterogeneous dose distributions in systemic radiotherapy. Med Phys (2006) 0.77
Hypofractionated Conformal Radiotherapy (HCRT) for primary and metastatic lung cancers with small dimension : efficacy and toxicity. Strahlenther Onkol (2009) 0.77
Monitoring of people and workers exposure to the electric, magnetic and electromagnetic fields in an Italian National Cancer Institute. J Exp Clin Cancer Res (2008) 0.77